Kyongbo Pharmaceutical Co., Ltd (KRX:214390)
South Korea · Delayed Price · Currency is KRW 5,140.00
+40.00 (0.78%)
At close: Jul 25, 2025, 3:30 PM KST
Kyongbo Pharmaceutical Market Cap
Kyongbo Pharmaceutical has a market cap or net worth of 122.88 billion as of July 25, 2025. Its market cap has decreased by -27.09% in one year.
Market Cap
122.88B
Enterprise Value
217.39B
Revenue
236.54B
Ranking
n/a
PE Ratio
53.55
Stock Price
5,140.00
Market Cap Chart
Since June 29, 2015, Kyongbo Pharmaceutical's market cap has decreased from 818.81B to 122.88B, a decrease of -84.99%. That is a compound annual growth rate of -17.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2025 | 122.88B | -17.36% |
| Dec 30, 2024 | 148.70B | -25.86% |
| Dec 28, 2023 | 200.58B | -16.10% |
| Dec 29, 2022 | 239.07B | -6.98% |
| Dec 30, 2021 | 257.00B | -34.25% |
| Dec 30, 2020 | 390.88B | 97.94% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 75.73T |
| Celltrion | 39.71T |
| ALTEOGEN | 25.60T |
| Yuhan | 9,359.37B |
| SK Biopharmaceuticals | 7,964.46B |
| Peptron | 6,907.66B |
| HLB Co., Ltd. | 6,558.63B |
| PharmaResearch | 6,057.16B |